Navigation Links
UC San Diego announces collaboration with Johnson & Johnson Pharmaceutical Research & Development
Date:11/20/2008

University of California, San Diego Health Sciences leaders have announced that they have executed a formal Memorandum of Understanding (MOU) with Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), with the objective of developing future collaborations in biomedical research and education to advance human health.

The MOU establishes a framework for future research and training efforts between the UC San Diego School of Medicine, Skaggs School of Pharmacy and Pharmaceutical Sciences and the UC San Diego Medical Center health system, and J&JPRD, a pharmaceutical research and development company with expertise in small molecules, genomics, bioinformatics, high throughput screening, and structural biology.

"We are excited about this tremendous opportunity to partner with J&JPRD, which is a world leader in the development of new drugs. This collaboration will further accelerate our efforts at UC San Diego to translate the exciting discoveries being made every day in our laboratories into improved diagnostic and treatment technologies that benefit all patients," said David Brenner, M.D., UC San Diego Vice Chancellor for Health Sciences. "The ability to work more closely with colleagues in the private sector will strengthen our translational research program, and enhance the education of our medical, pharmacy and graduate students, in addition to boosting the potential for new product development."

Brenner joined with G. Diego Miralles, M.D., Head and Chief Medical Officer of J&JPRD's Research and Early Development unit based in San Diego, to sign the MOU in ceremonies at the UC San Diego School of Medicine.

Echoing Dr. Brenner's enthusiasm, Dr. Miralles noted that "academia and industry are natural partners since we have complimentary expertise and share the common goal of addressing unmet medical needs. Working closely with our neighbors at UCSD will help us find win-win opportunities and maximize our common capabilities. We are very excited about the potential of this partnership."

The two organizations plan to create education, training and research collaborations in biomedical science, medicine and public health, with a focus on projects that lead to new clinical applications. In addition to signing the MOU, the organizations also signed the first agreement between UC San Diego Health Sciences and J&JPRD under the MOU framework a contract for UC San Diego Professor of Pharmacology Larry Brunton, Ph.D., to conduct laboratory studies to evaluate the effects of new compounds on heart tissue.


'/>"/>

Contact: Leslie Franz
lfranz@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
2. Centennial Taking Control of Your Diabetes Conference Returns to San Diego to Bring Answers, Advocacy and Hope
3. Dr. Ron Greenspan has Been Selected for the 2008 Best of San Diego Award in the Orthodontists Category by the U.S. Local Business Association
4. Car Donations: "Tired Wheels" Turned Into Donation Dollars for Ronald McDonald House Charities, San Diego
5. UC San Diego to lead nationwide program in pharmacogenomics
6. Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
7. Graves & Thyroid Disease National Patient Conference Set for San Diego, CA
8. Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008
9. Direct From Beijing, 2008 Olympic Gymnastic Superstars and Grammy Award Winning Icons Descend Upon San Diego to Tape ABC Network Womens Cancer Awareness Special, Frosted Pink With A Twist
10. San Diego Supercomputer Center director urges academia to make cyberinfrastructure real
11. CRH Medical Corporation opens Center in San Diego California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Story Highlights: ... the health care industry is causing providers to review ... Deloitte offers a suite of solutions for health care ... cost optimization: labor resource analysis, revenue cycle optimization and ... outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
Breaking Medicine Technology: